MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation

K. Knudsen, T. Fedorova, K. Østergaard, P. Borghammer (Aarhus, Denmark)

Meeting: 2017 International Congress

Abstract Number: 40

Keywords: Autonomic dysfunction

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To study plasma PP concentration during sham feeding in PD patients and healthy controls, as a measure of pancreatic vagal innervation.

Background:

Most patients with Parkinson’s disease (PD) experience signs of decreased parasympathetic function. Lewy pathology is present in the vagus nerve and the dorsal motor nucleus of the vagus very early in the disease course (Braak stage I). The pancreas is densely innervated by the vagus nerve, and the early peak (5-20 min) of the hormone Pancreatic Polypeptide (PP) after food intake or sham-feeding has been validated as a marker of vagal integrity. Thus, we aimed to study plasma PP concentration during sham feeding (chew-and-spit) in PD patients and healthy controls (HC), as a measure of pancreatic vagal innervation.

Methods:

Twenty-five early-to-moderate PD patients (H&Y 2 (1-3); 7 female) and 17 HC (5 female) were included. Blood sampling for analysis of PP, glucose, and insulin levels were performed before, during, and 20 minutes after a 5 minute sham feeding session with white bread and chocolate spread. Furthermore, faeces samples from all participants were analysed for pancreatic elastase enzyme levels as a marker of exocrine pancreatic function.

Results:

The PD group displayed significantly decreased plasma PP concentrations during the early phase after sham feeding compared to controls (p=0.012). No change in glucose and insulin levels were seen in any of the groups as an indicator of pure sham feeding without food ingestion. Also, no significant group difference was seen in pancreatic elastase levels (p=0.69).

Conclusions:

Early-to-moderate stage PD patients showed significantly decreased PP plasma concentrations after sham feeding – an indication of decreased vagal function. Exocrine pancreatic function measured by elastase in faeces was not significantly different in the patient group compared to controls.

 Glucose and insulin concentrations did not change in either group throughout the test, verifying that sham feeding was performed correctly without unintentional swallowing of food.

To cite this abstract in AMA style:

K. Knudsen, T. Fedorova, K. Østergaard, P. Borghammer. Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/pancreatic-polypeptide-plasma-levels-in-parkinsons-disease-a-marker-of-parasympathetic-denervation/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/pancreatic-polypeptide-plasma-levels-in-parkinsons-disease-a-marker-of-parasympathetic-denervation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley